|
ABOUT COMPANY
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 909151000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.263
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -159303008
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|